Tower Research Capital (TRC)’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.3K | Sell |
2,781
-14,752
| -84% | -$166K | ﹤0.01% | 3367 |
|
|
2025
Q1 | $99.9K | Buy |
17,533
+561
| +3% | +$3.2K | ﹤0.01% | 1770 |
|
|
2024
Q4 | $167K | Sell |
16,972
-3,899
| -19% | -$38.3K | ﹤0.01% | 1837 |
|
|
2024
Q3 | $170K | Buy |
20,871
+17,243
| +475% | +$141K | ﹤0.01% | 1768 |
|
|
2024
Q2 | $48.5K | Buy |
3,628
+560
| +18% | +$7.48K | ﹤0.01% | 3123 |
|
|
2024
Q1 | $142K | Sell |
3,068
-7,654
| -71% | -$355K | ﹤0.01% | 1632 |
|
|
2023
Q4 | $725K | Buy |
10,722
+10,156
| +1,794% | +$687K | 0.01% | 1080 |
|
|
2023
Q3 | $40.9K | Sell |
566
-142
| -20% | -$10.3K | ﹤0.01% | 2716 |
|
|
2023
Q2 | $52.7K | Sell |
708
-3,206
| -82% | -$239K | ﹤0.01% | 2520 |
|
|
2023
Q1 | $208K | Sell |
3,914
-964
| -20% | -$51.2K | 0.01% | 1344 |
|
|
2022
Q4 | $330K | Sell |
4,878
-465
| -9% | -$31.5K | 0.01% | 959 |
|
|
2022
Q3 | $667K | Buy |
5,343
+3,084
| +137% | +$385K | 0.01% | 918 |
|
|
2022
Q2 | $215K | Buy |
2,259
+2,213
| +4,811% | +$211K | ﹤0.01% | 1716 |
|
|
2022
Q1 | $7K | Buy |
46
+15
| +48% | +$2.28K | ﹤0.01% | 4709 |
|
|
2021
Q4 | $10K | Buy |
31
+13
| +72% | +$4.19K | ﹤0.01% | 4550 |
|
|
2021
Q3 | $8K | Buy |
+18
| New | +$8K | ﹤0.01% | 4528 |
|